To combat osmidrosis (bad odour) and/or bromhidrosis (excess sweating) in cancer patients undergoing radiotherapy and/or chemotherapy. It is also indicated in subjects affected by osmidrosis.
For the treatment of skin disorders such as maceration, redness, desquamation and/or dehydration in subjects exposed to radiation as well as to heat and chemical stress, and in the post-septic phase and post-operative period.
For the treatment of skin disorders including itchy, irritated and reddened skin due to the exposure to radiation as well as to heat and chemical stress, and as an adjunctive support in post-septic states and the post-operative period.